scholarly article | Q13442814 |
P2093 | author name string | D. A. Lindsay | |
J. P. Seale | |||
S. D. Anderson | |||
G. Theobald | |||
L. Bandler | |||
P. Rozea | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 493-500 | |
P577 | publication date | 1976-09-01 | |
P1433 | published in | The American Review of Respiratory Disease | Q26839505 |
P1476 | title | Inhaled and oral salbutamol in exercise-induced asthma | |
P478 | volume | 114 |
Q36095894 | A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue |
Q36973812 | A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes |
Q67275247 | Aerosol Bronchodilators in Preventive Treatment of Asthma |
Q42927187 | Aerosol bronchodilators and hand-lung dyscoordination |
Q36645443 | Beta2-agonists and exercise-induced asthma |
Q28263755 | British Thoracic Society summer meeting. 11-13 July 1990, Birmingham. Abstracts |
Q34689404 | Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma |
Q39550681 | Bronchorelaxation and plasma histamine after salbutamol inhalation |
Q40088779 | Combination Bronchodilator Therapy |
Q42128720 | Control of asthma |
Q40091523 | Current Status of Beta-Adrenergic Agonists in Bronchial Asthma |
Q53219510 | Current issues with beta2-adrenoceptor agonists: historical background. |
Q67929157 | Duration of protection of calcium channel blockers against exercise-induced bronchospasm: comparison of oral diltiazem and inhaled gallopamil |
Q36472509 | Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects |
Q36274565 | Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol |
Q36209550 | Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma |
Q34995018 | Effect of terbutaline sulphate in chronic "allergic" cough |
Q54337946 | Efficacy of formoterol metered aerosol in children. |
Q72727397 | Exercise-induced asthma |
Q41885947 | Inhalation treatment for asthma |
Q35788055 | Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future |
Q35143482 | Management of asthma in adults: current therapy and future directions |
Q36445477 | Protective effect of drugs on histamine-induced asthma |
Q36465654 | Protective effects of repeated short sprints in exercise-induced asthma |
Q36905826 | Review of prescribed treatment for children with asthma in 1990. |
Q40085348 | Strategies in the Control of Asthma |
Q70553429 | Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres |
Q70758665 | The Effects of Oral Doses of Theophylline and Fenoterol on Exercise-Induced Asthma |
Q70280369 | The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol |
Q72164993 | The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction |
Q39433487 | The use of anti-asthmatic drugs. Do they affect sports performance? |
Q66902622 | Theophylline for treatment of asthma |
Q40093004 | Therapeutic aerosols 2--Drugs available by the inhaled route |
Q40176951 | Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma |
Q34986817 | Use of salbutamol powder in childhood asthma |
Search more.